Artículos del autor

solaci

III Summit ICBA LATAM CTO | Free Registration for SOLACI Members!

On May 11, 2020, from 2 to 6 pm, the III Summit ICBA LATAM CTO will be...

Impella and Adverse Events

Long after AHA 2019 had presented observational studies showing adverse events associated to Impella, JAMA is finally...

SOLACI Research | SOLACI’s Innovative Research Area

We have the pleasure to announce the creation of SOLACI's research department under the name "SOLACI Research",...

ACC Recommendations against the New Coronavirus

The American College of Cardiology (ACC) has launched a document summarizing the potential implications of the new...

What to Do and What Not to Do in Case of PE According to the New European Guidelines

As a “friendly,” easy-to-read document, the new European guidelines on pulmonary embolism (PE) include an excellent summary...

TAVR: Should Transradial Approach be the Second Access Site?

Courtesy of Dr. Carlos Fava. One of the major challenges we interventional cardiologists still face is access management....

Alternatives for Patients Allergic to Aspirin

Intolerance to aspirin is relatively frequent and there is no other non-steroid anti-inflammatory medication to replace it. The...

Chronic Coronary Syndromes Nowadays

Multiple drugs and treatment strategies have emerged in recent years to change significantly the prognosis of patients...